Found 46 matching trials
Multi-CAR-T Cells Targeting B Cell Lymphomas PHASE1 This study aims to evaluate safety and efficacy of a combination of 4th gen...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas PHASE1 This is a pilot clinical trial investigating the addition of haploidentical...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients PHASE1 The purpose of this study is to evaluate the safety and effectiveness of CA...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. PHASE1 Title: Safety and efficacy of CAR-T cell therapy for relapsed/refractory ne...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
GD2/CD70 Bi-specific CAR-T Cell Therapy PHASE1 The purpose of this study is to assess the feasibility, safety and efficacy...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial
Combination Chemotherapy, Monoclonal Antibody, and Natural Killer Cells in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE1 This is a safety / feasibility trial evaluating the combination of a humani...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors PHASE1 This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Combination Immunotherapy Targeting Sarcomas PHASE1 The aim of this clinical trial is to assess the feasibility, safety and eff...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
GD2/CD56 Bi-specific CAR-T Cell Therapy PHASE1 The purpose of this clinical trial is to assess the feasibility, safety and...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma PHASE1 The purpose of this clinical trial is to assess the feasibility, safety and...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial